Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    12 days ago
    Change Detected
    Summary
    Added related topics: Ovarian cancer and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-02-25T20:04:36.000Z thumbnail image
  2. Check
    19 days ago
    Change Detected
    Summary
    Related topic tags 'Ovarian cancer' and 'MedlinePlus Genetics' were removed from the study record's metadata. This changes how the page is categorized and surfaced in topic-based searches.
    Difference
    0.2%
    Check dated 2026-02-18T16:41:35.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed prior notices including the lapse in government funding notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:26:33.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:29:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    New UI elements include a Show glossary option and a Revision: v3.4.0 note, along with minor QC-label edits and capitalization tweaks for No FEAR Act Data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:14:17.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added related topics 'Ovarian cancer' and MedlinePlus Genetics, and updated revision from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T02:58:02.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.